commit 6eb274384f0c4cd30cc83f08ce097956913930ce
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Wed Dec 4 08:42:13 2024 +0100

    DEC 2024

diff --git a/Epidemiological data/Rare disease epidemiology/cs_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/cs_product9_prev.xml
index 593f27e..c24cf38 100644
--- a/Epidemiological data/Rare disease epidemiology/cs_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/cs_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="UTF-8"?>
-<JDBOR date="2024-07-01 09:28:58" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2024-12-03 07:13:39" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6076">
+  <DisorderList count="6150">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=166024</ExpertLink>
@@ -32844,55 +32844,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="418">
-      <OrphaCode>1135</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=1135</ExpertLink>
-      <Name lang="cs">Syndrom zahrnující arhinii, atrézii choan a mikroftalmii</Name>
-      <DisorderType id="21401">
-        <Name lang="cs">Malformační syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="1078">
-          <Source>672092[PMID]_8723126[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="cs">Případy / rodiny</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="cs">Případ</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1079">
-          <Source>ORPHANET_672092[PMID]_8723126[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="cs">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17764">
       <OrphaCode>168454</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=168454</ExpertLink>
@@ -68522,55 +68473,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="890">
-      <OrphaCode>1935</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=1935</ExpertLink>
-      <Name lang="cs">Časná myoklonická encefalopatie</Name>
-      <DisorderType id="21422">
-        <Name lang="cs">Klinický syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="2473">
-          <Source>20821848[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="cs">Případy / rodiny</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="cs">Případ</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>80.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2474">
-          <Source>ORPHANET_20821848[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="cs">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="892">
       <OrphaCode>1943</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=1943</ExpertLink>
@@ -79452,7 +79354,7 @@
       <DisorderGroup id="36547">
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
+      <PrevalenceList count="10">
         <Prevalence id="2595">
           <Source>European Medicines Agency 2012[INST]</Source>
           <PrevalenceType id="23669">
@@ -79491,6 +79393,120 @@
             <Name lang="cs">Ověřeno</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17611">
+          <Source>32201678[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.86</ValMoy>
+          <PrevalenceGeographic id="25062">
+            <Name lang="cs">Peru</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17612">
+          <Source>https://www.ncbi.nlm.nih.gov/books/NBK1212/</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.1</ValMoy>
+          <PrevalenceGeographic id="25006">
+            <Name lang="cs">Norsko</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17613">
+          <Source>https://www.ncbi.nlm.nih.gov/books/NBK1212/</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="24705">
+            <Name lang="cs">Libanon</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17614">
+          <Source>https://www.ncbi.nlm.nih.gov/books/NBK1212/</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2</ValMoy>
+          <PrevalenceGeographic id="25090">
+            <Name lang="cs">Portugalsko</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17615">
+          <Source>15767751[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="cs">Prevalence při narození</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="25013">
+            <Name lang="cs">Omán</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17616">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.6812</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13422">
           <Source>27144933[PMID]</Source>
           <PrevalenceType id="23669">
@@ -79512,8 +79528,8 @@
         </Prevalence>
         <Prevalence id="17072">
           <Source>35209917[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="cs">Prevalence při narození</Name>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="cs">Hodnota a třída</Name>
@@ -84280,11 +84296,11 @@
       <OrphaCode>1580</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=1580</ExpertLink>
       <Name lang="cs">Distální monozomie 10p</Name>
-      <DisorderType id="21401">
-        <Name lang="cs">Malformační syndrom</Name>
+      <DisorderType id="21436">
+        <Name lang="cs">Klinická skupina</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
+      <DisorderGroup id="36540">
+        <Name lang="cs">Skupina onemocnění</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="2727">
@@ -89868,55 +89884,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1335">
-      <OrphaCode>1027</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=1027</ExpertLink>
-      <Name lang="cs">Autozomálně recesivní amélie</Name>
-      <DisorderType id="21401">
-        <Name lang="cs">Malformační syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="2854">
-          <Source>7625439[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="cs">Případy / rodiny</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="cs">Případ</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2855">
-          <Source>ORPHANET_7625439[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="cs">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="16886">
       <OrphaCode>139402</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=139402</ExpertLink>
@@ -128980,38 +128947,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2535">
-      <OrphaCode>2787</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=2787</ExpertLink>
-      <Name lang="cs">Syndrom zahrnující osteoporózu, makrocefalii, slepotu a kloubní hyperlaxitu</Name>
-      <DisorderType id="21401">
-        <Name lang="cs">Malformační syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="3843">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="cs">neznámý</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="cs">Dosud neoveřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="19750">
       <OrphaCode>254449</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=254449</ExpertLink>
@@ -243305,55 +243240,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="23328">
-      <OrphaCode>436151</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=436151</ExpertLink>
-      <Name lang="cs">Syndrom zahrnující mentální retardaci, expresivní afázii a faciální dysmorfismus</Name>
-      <DisorderType id="21394">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="11544">
-          <Source>25217958[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="cs">Případy / rodiny</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="cs">Případ</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>13.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="11545">
-          <Source>ORPHANET_25217958[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="cs">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="23331">
       <OrphaCode>436169</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=436169</ExpertLink>
@@ -272757,11 +272643,11 @@
       <OrphaCode>31740</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=31740</ExpertLink>
       <Name lang="cs">Hypersenzitivní pneumonitida</Name>
-      <DisorderType id="21436">
-        <Name lang="cs">Klinická skupina</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
       </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="cs">Skupina onemocnění</Name>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="5426">
@@ -278079,57 +277965,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10958">
-      <OrphaCode>70587</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=70587</ExpertLink>
-      <Name lang="cs">Syndrom dechové tísně novorovozence</Name>
-      <DisorderType id="21394">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="6055">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23676">
-            <Name lang="cs">Každoroční výskyt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="cs">Hodnota a třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="cs">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.5</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="cs">Evropa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="cs">Dosud neoveřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="6056">
-          <Source>European Medicines Agency[INST]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="cs">Hodnota a třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="cs">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>20.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="cs">Evropa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10945">
       <OrphaCode>70472</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=70472</ExpertLink>
@@ -284375,38 +284210,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10775">
-      <OrphaCode>57777</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=57777</ExpertLink>
-      <Name lang="cs">Cirhotická kardiomyopatie</Name>
-      <DisorderType id="21394">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="5827">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="cs">neznámý</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="cs">Dosud neoveřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10774">
       <OrphaCode>57196</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=57196</ExpertLink>
@@ -302925,55 +302728,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10656">
-      <OrphaCode>50817</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=50817</ExpertLink>
-      <Name lang="cs">Syndrom zahrnující Duaneho anomálii, myopatii a skoliózu</Name>
-      <DisorderType id="21394">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="cs">Onemocnění</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="5710">
-          <Source>14659780[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="cs">Případy / rodiny</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="cs">Případ</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5711">
-          <Source>ORPHANET_14659780[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="cs">Bod prevalence</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="cs">Pouze třída</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="cs">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="cs">Celosvětově</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="cs">Ověřeno</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10660">
       <OrphaCode>50918</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=50918</ExpertLink>
@@ -336763,6 +336517,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30684">
+      <OrphaCode>610573</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=610573</ExpertLink>
+      <Name lang="cs">Syndrom progresivní neurodegenerace a periferní neuropatie s nástupem v dětství související s CLCN6</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17569">
+          <Source>33217309[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17570">
+          <Source>33217309[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="30683">
       <OrphaCode>610569</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=610569</ExpertLink>
@@ -337008,6 +336811,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30690">
+      <OrphaCode>611216</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=611216</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující aplastickou anémii, mentální retardaci a malý vzrůst</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17571">
+          <Source>33355142[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17572">
+          <Source>33355142[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30691">
+      <OrphaCode>611223</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=611223</ExpertLink>
+      <Name lang="cs">Dorzoventrální syndrom související s EN1</Name>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17573">
+          <Source>33568816[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17574">
+          <Source>33568816[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="30688">
       <OrphaCode>611201</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=611201</ExpertLink>
@@ -372467,6 +372368,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31747">
+      <OrphaCode>643549</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=643549</ExpertLink>
+      <Name lang="cs">Haoův-Fountainův syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17703">
+          <Source>26365382[PMID]_30679821[PMID]_35627274[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17704">
+          <Source>26365382[PMID]_30679821[PMID]_35627274[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14528">
       <OrphaCode>99955</OrphaCode>
       <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=99955</ExpertLink>
@@ -376139,10 +376089,549 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="31322">
-      <OrphaCode>615970</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=615970</ExpertLink>
-      <Name lang="cs">Chronická intervilozitida neznámé etiologie</Name>
+    <Disorder id="31580">
+      <OrphaCode>631073</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631073</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 82</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17667">
+          <Source>31637422[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17668">
+          <Source>31637422[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31581">
+      <OrphaCode>631076</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631076</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 83</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17665">
+          <Source>32707086[PMID]_33188300[PMID]_33970200[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>16.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17666">
+          <Source>32707086[PMID]_33188300[PMID]_33970200[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31582">
+      <OrphaCode>631079</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631079</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 84</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17663">
+          <Source>34415322[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17664">
+          <Source>34415322[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31583">
+      <OrphaCode>631082</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631082</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 85</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17661">
+          <Source>31636353[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17662">
+          <Source>31636353[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31579">
+      <OrphaCode>631068</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631068</ExpertLink>
+      <Name lang="cs">Autozomálně dominantní spastická paraplegie, typ 80</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17669">
+          <Source>30929741[PMID]_ 31203368[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17670">
+          <Source>30929741[PMID]_ 31203368[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31591">
+      <OrphaCode>631106</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631106</ExpertLink>
+      <Name lang="cs">Spinocerebelární ataxie, typ 49</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17647">
+          <Source>35310830[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17648">
+          <Source>35310830[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31590">
+      <OrphaCode>631103</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631103</ExpertLink>
+      <Name lang="cs">Spinocerebelární ataxie, typ 48</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17649">
+          <Source>34070858[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>50.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17650">
+          <Source>34070858[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31588">
+      <OrphaCode>631095</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631095</ExpertLink>
+      <Name lang="cs">Spinocerebelární ataxie, typ 44</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17651">
+          <Source>28886343[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17652">
+          <Source>28886343[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31585">
+      <OrphaCode>631088</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631088</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 87</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17657">
+          <Source>35718349[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17658">
+          <Source>35718349[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31584">
+      <OrphaCode>631085</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631085</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní spastická paraplegie, typ 86</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17659">
+          <Source>34866177[PMID]_34489854[PMID]_34587489[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17660">
+          <Source>34866177[PMID]_34489854[PMID]_34587489[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31592">
+      <OrphaCode>631248</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=631248</ExpertLink>
+      <Name lang="cs">Mitchellův syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17655">
+          <Source>32169171[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17656">
+          <Source>32169171[PMID] _ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31692">
+      <OrphaCode>634475</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=634475</ExpertLink>
+      <Name lang="cs">Mozaiková forma schwannomatózy asociovaná s NF2</Name>
       <DisorderType id="21394">
         <Name lang="cs">Onemocnění</Name>
       </DisorderType>
@@ -376150,8 +376639,8 @@
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="17494">
-          <Source>32841927[PMID]_ORPHANET</Source>
+        <Prevalence id="17680">
+          <Source>35674741[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="cs">Bod prevalence</Name>
           </PrevalenceType>
@@ -376171,19 +376660,89 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="31346">
-      <OrphaCode>617408</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617408</ExpertLink>
-      <Name lang="cs">Klasická eozinofilní pustulózní folikulitida</Name>
+    <Disorder id="31693">
+      <OrphaCode>634492</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=634492</ExpertLink>
+      <Name lang="cs">Mozaiková forma schwannomatózy</Name>
       <DisorderType id="21394">
         <Name lang="cs">Onemocnění</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="17493">
-          <Source>37983361[PMID]_ORPHANET</Source>
+      <PrevalenceList count="3">
+        <Prevalence id="17681">
+          <Source>29909380[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17682">
+          <Source>29909380[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.7928</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="cs">Spojené království</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17683">
+          <Source>29909380[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="cs">Prevalence při narození</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.4502</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="cs">Spojené království</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31691">
+      <OrphaCode>634461</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=634461</ExpertLink>
+      <Name lang="cs">Mozaiková neurofibromatóza, typ 1</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17678">
+          <Source>20301288[PMID]_29215653[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="cs">Bod prevalence</Name>
           </PrevalenceType>
@@ -376201,12 +376760,180 @@
             <Name lang="cs">Ověřeno</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17679">
+          <Source>29215653[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="cs">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>24.4618</ValMoy>
+          <PrevalenceGeographic id="24362">
+            <Name lang="cs">Finsko</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31680">
+      <OrphaCode>633228</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=633228</ExpertLink>
+      <Name lang="cs">Proximální fokální femorální deficience</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17653">
+          <Source>32019581[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.55</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17654">
+          <Source>32019581[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="cs">Prevalence při narození</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.55</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="31468">
-      <OrphaCode>623789</OrphaCode>
-      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=623789</ExpertLink>
-      <Name lang="cs">Dysforie tělesné integrity</Name>
+    <Disorder id="31705">
+      <OrphaCode>637064</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=637064</ExpertLink>
+      <Name lang="cs">Izolovaná aplázie zrakového nervu</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17686">
+          <Source>29676329[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17687">
+          <Source>29676329[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31704">
+      <OrphaCode>637061</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=637061</ExpertLink>
+      <Name lang="cs">Izolovaná hypoplázie zrakového nervu</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17684">
+          <Source>24082663[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>25.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17685">
+          <Source>24082663[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31703">
+      <OrphaCode>637051</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=637051</ExpertLink>
+      <Name lang="cs">Bornavirová encefalitida</Name>
       <DisorderType id="21394">
         <Name lang="cs">Onemocnění</Name>
       </DisorderType>
@@ -376214,8 +376941,208 @@
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="17263">
-          <Source>ORPHANET</Source>
+        <Prevalence id="17690">
+          <Source>31924550[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17691">
+          <Source>31924550[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31697">
+      <OrphaCode>636945</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=636945</ExpertLink>
+      <Name lang="cs">Invazivní kandidóza</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17695">
+          <Source>27394927[PMID]_32809459[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17696">
+          <Source>27394927[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.5</ValMoy>
+          <PrevalenceGeographic id="24369">
+            <Name lang="cs">Francie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31696">
+      <OrphaCode>636941</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=636941</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující vaskulární Ehlersův-Danlosův syndrom a polymikrogyrii</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17688">
+          <Source>29499446[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17689">
+          <Source>29499446[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31699">
+      <OrphaCode>636955</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=636955</ExpertLink>
+      <Name lang="cs">Endemický pemphigus foliaceus</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17693">
+          <Source>34909708[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17694">
+          <Source>34909708[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.4</ValMoy>
+          <PrevalenceGeographic id="25419">
+            <Name lang="cs">Tunisko</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31698">
+      <OrphaCode>636950</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=636950</ExpertLink>
+      <Name lang="cs">Onemocnění s glaukomatocyklitickými krizemi</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17692">
+          <Source>35015437[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="cs">Bod prevalence</Name>
           </PrevalenceType>
@@ -376226,6 +377153,55 @@
             <Name lang="cs">neznámý</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31727">
+      <OrphaCode>641829</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641829</ExpertLink>
+      <Name lang="cs">Novorozenecký kompartment syndrom</Name>
+      <DisorderType id="21422">
+        <Name lang="cs">Klinický syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17705">
+          <Source>35415493[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>60.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17706">
+          <Source>35415493[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="cs">Celosvětově</Name>
           </PrevalenceGeographic>
@@ -376233,18 +377209,2525 @@
             <Name lang="cs">Ověřeno</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="17264">
-          <Source>ORPHANET</Source>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31725">
+      <OrphaCode>641496</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641496</ExpertLink>
+      <Name lang="cs">Schizofrenie s nástupem v dětství</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17713">
+          <Source>22906158[PMID]_ORPHANET</Source>
           <PrevalenceType id="23676">
             <Name lang="cs">Každoroční výskyt</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23704">
             <Name lang="cs">Pouze třída</Name>
           </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="cs">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17714">
+          <Source>22906158[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
           <PrevalenceClass id="23774">
             <Name lang="cs">neznámý</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31722">
+      <OrphaCode>641390</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641390</ExpertLink>
+      <Name lang="cs">PsAPASH syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17701">
+          <Source>32942279[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17702">
+          <Source>32942279[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31720">
+      <OrphaCode>641380</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641380</ExpertLink>
+      <Name lang="cs">PAPASH syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17697">
+          <Source>32942279[PMID]_35034021[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>20.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17698">
+          <Source>32942279[PMID]_35034021[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31721">
+      <OrphaCode>641385</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641385</ExpertLink>
+      <Name lang="cs">PASS syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17699">
+          <Source>32942279[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>16.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17700">
+          <Source>32942279[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31716">
+      <OrphaCode>641368</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641368</ExpertLink>
+      <Name lang="cs">Autozomálně recesivní hyper-IgE syndrom způsobený deficitem ZNF341</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17715">
+          <Source>30264496[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>61.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17716">
+          <Source>30264496[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31714">
+      <OrphaCode>641353</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641353</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující neurodegeneraci, progresivní spasticitu, mentální retardaci a léze bílé hmoty projevující se v dětském věku</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17709">
+          <Source>35985664[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>32.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17710">
+          <Source>35985664[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31715">
+      <OrphaCode>641361</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641361</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující neurovývojové opoždění, hypotonii, cerebelární ataxii a poruchy srdečního vedení</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17707">
+          <Source>34089229[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17708">
+          <Source>34089229[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31713">
+      <OrphaCode>641350</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=641350</ExpertLink>
+      <Name lang="cs">Hypofyzitida vyvolaná imunoterapií</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17711">
+          <Source>28702249[PMID]_34430146[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="cs">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>12.8074</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17712">
+          <Source>28702249[PMID]_34430146[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31731">
+      <OrphaCode>642099</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=642099</ExpertLink>
+      <Name lang="cs">Spondyloepimetafyzární dysplázie s kloubní laxicitou, Beightonův typ</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17717">
+          <Source>27245527[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17718">
+          <Source>27245527[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31730">
+      <OrphaCode>642085</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=642085</ExpertLink>
+      <Name lang="cs">Spondyloepimetafyzární dysplázie s kloubní laxicitou, typ EXOC6B</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17719">
+          <Source>36150098[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17720">
+          <Source>36150098[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31660">
+      <OrphaCode>633004</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=633004</ExpertLink>
+      <Name lang="cs">Syndrom související s KDM3B zahrnující mentální retardaci, obličejovou dysmorfii a malý vzrůst</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17676">
+          <Source>30929739[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17677">
+          <Source>30929739[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31661">
+      <OrphaCode>633014</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=633014</ExpertLink>
+      <Name lang="cs">Syndrom související s SLC12A2 zahrnující senzorineurální hluchotu, opoždění vývoje a mentální retardaci</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17671">
+          <Source>34797034[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17672">
+          <Source>34797034[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31676">
+      <OrphaCode>633124</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=633124</ExpertLink>
+      <Name lang="cs">Invazivní infekce druhem Scopulariopsis</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17675">
+          <Source>https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2563</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.05</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31664">
+      <OrphaCode>633028</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=633028</ExpertLink>
+      <Name lang="cs">Syndrom související s CPE podobný Praderovu-Williho syndromu</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17673">
+          <Source>26120850[PMID]_32936766[PMID]_34383079[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17674">
+          <Source>26120850[PMID]_32936766[PMID]_34383079[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31322">
+      <OrphaCode>615970</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=615970</ExpertLink>
+      <Name lang="cs">Chronická intervilozitida neznámé etiologie</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17494">
+          <Source>32841927[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31346">
+      <OrphaCode>617408</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617408</ExpertLink>
+      <Name lang="cs">Klasická eozinofilní pustulózní folikulitida</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17493">
+          <Source>37983361[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31340">
+      <OrphaCode>617304</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617304</ExpertLink>
+      <Name lang="cs">Embolie plodovou vodou</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17578">
+          <Source>31714909[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="cs">Spojené království</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31337">
+      <OrphaCode>617294</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617294</ExpertLink>
+      <Name lang="cs">Sekvence anémie-polycytémie u dvojčat (TAPS)</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17575">
+          <Source>27068715[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31339">
+      <OrphaCode>617301</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617301</ExpertLink>
+      <Name lang="cs">Selektivní nitroděložní růstová restrikce</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17577">
+          <Source>28532678[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31338">
+      <OrphaCode>617297</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617297</ExpertLink>
+      <Name lang="cs">Sekvence reverzní arteriální perfuze u dvojčat (TRAP)</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17576">
+          <Source>20522408[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31449">
+      <OrphaCode>621758</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=621758</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující  fibrózu, neurodegeneraci a mozkovou angiomatózu</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17608">
+          <Source>34165204[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17609">
+          <Source>34165204[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31442">
+      <OrphaCode>620371</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620371</ExpertLink>
+      <Name lang="cs">Gitelman-like tubulopatie ledvin způsobená mutací mitochondriální DNA</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17604">
+          <Source>15498972[PMID]_34607911[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23725">
+            <Name lang="cs">Rodina</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>14.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17605">
+          <Source>15498972[PMID]_34607911[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31441">
+      <OrphaCode>620368</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620368</ExpertLink>
+      <Name lang="cs">EGF asociovaná primární hypomagnezémie s intelektovou nedostatečností</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17602">
+          <Source>33600043[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>11.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17603">
+          <Source>33600043[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31440">
+      <OrphaCode>620363</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620363</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující primární hypomagnezémii, generalizované záchvaty, intelektovou nedostatečnost a obezitu</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17600">
+          <Source>33600043[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>11.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17601">
+          <Source>33600043[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31436">
+      <OrphaCode>620205</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620205</ExpertLink>
+      <Name lang="cs">Nesyndromická bikoronární a sagitální kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17625">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31437">
+      <OrphaCode>620212</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620212</ExpertLink>
+      <Name lang="cs">Nesyndromická pansynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17626">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31434">
+      <OrphaCode>620192</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620192</ExpertLink>
+      <Name lang="cs">Nesyndromická metopická a sagitální kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17623">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31435">
+      <OrphaCode>620198</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620198</ExpertLink>
+      <Name lang="cs">Nesyndromická bikoronární a metopická kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17624">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31432">
+      <OrphaCode>620178</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620178</ExpertLink>
+      <Name lang="cs">Nesyndromická bilambdoidní kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17621">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31433">
+      <OrphaCode>620186</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620186</ExpertLink>
+      <Name lang="cs">Nesyndromická unikoronární a sagitální kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17622">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31431">
+      <OrphaCode>620158</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620158</ExpertLink>
+      <Name lang="cs">Nesyndromická nespecifikovaná multisuturální kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17620">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31428">
+      <OrphaCode>620139</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620139</ExpertLink>
+      <Name lang="cs">Nesyndromická unifrontosfenoidální kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17618">
+          <Source>29065043[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0136</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31429">
+      <OrphaCode>620146</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620146</ExpertLink>
+      <Name lang="cs">Nesyndromická uniskvamózní kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17619">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31426">
+      <OrphaCode>620102</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620102</ExpertLink>
+      <Name lang="cs">Nesyndromická unikoronární kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17610">
+          <Source>35636659[PMID]_38348760[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.1049</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31427">
+      <OrphaCode>620113</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=620113</ExpertLink>
+      <Name lang="cs">Nesyndromická unilambdoidní kraniosynostóza</Name>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17617">
+          <Source>35636659[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0442</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31477">
+      <OrphaCode>624268</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624268</ExpertLink>
+      <Name lang="cs">Nespecifická autoimunitní cerebelární ataxie bez charakteristických protilátek</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17646">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31473">
+      <OrphaCode>624199</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624199</ExpertLink>
+      <Name lang="cs">Nespecifická autoimunitní encefalitida mozkového kmene s charakteristickými protilátkami</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17644">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31472">
+      <OrphaCode>624190</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624190</ExpertLink>
+      <Name lang="cs">Paraneoplastická izolovaná encefalitida mozkového kmene</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17641">
+          <Source>34827413[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31475">
+      <OrphaCode>624244</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624244</ExpertLink>
+      <Name lang="cs">Postinfekční cerebelitida</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17639">
+          <Source>31515702[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17640">
+          <Source>31515702[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31474">
+      <OrphaCode>624216</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624216</ExpertLink>
+      <Name lang="cs">Nespecifická autoimunitní encefalitida mozkového kmene bez charakteristických protilátek</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17645">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31468">
+      <OrphaCode>623789</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=623789</ExpertLink>
+      <Name lang="cs">Dysforie tělesné integrity</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17263">
+          <Source>25108391[PMID] _34237024[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.11</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31469">
+      <OrphaCode>623801</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=623801</ExpertLink>
+      <Name lang="cs">Akutní chabá myelitida</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="4">
+        <Prevalence id="17627">
+          <Source>36268734[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17628">
+          <Source>37817313[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.12</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="cs">Austrálie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17629">
+          <Source>32628734[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.06</ValMoy>
+          <PrevalenceGeographic id="24936">
+            <Name lang="cs">Nizozemsko</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17630">
+          <Source>36268734[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.04</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="cs">Spojené státy</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31470">
+      <OrphaCode>624166</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624166</ExpertLink>
+      <Name lang="cs">Nespecifická autoimunitní supratentoriální encefalitida s charakteristickými protilátkami</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17642">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31471">
+      <OrphaCode>624178</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=624178</ExpertLink>
+      <Name lang="cs">Nespecifická autoimunitní supratentoriální encefalitida bez charakteristických protilátek</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17643">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31464">
+      <OrphaCode>623615</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=623615</ExpertLink>
+      <Name lang="cs">Autoimunitní limbická encefalitida</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17631">
+          <Source>31552550[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.7</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17632">
+          <Source>31552550[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.25</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31465">
+      <OrphaCode>623626</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=623626</ExpertLink>
+      <Name lang="cs">Paraneoplastická cerebelární degenerace</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="6">
+        <Prevalence id="17633">
+          <Source>31552550[PMID]_32847939[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.9553</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17634">
+          <Source>31552550[PMID]_32847939[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2225</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="cs">Evropa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17635">
+          <Source>32847939[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.6869</ValMoy>
+          <PrevalenceGeographic id="24369">
+            <Name lang="cs">Francie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17636">
+          <Source>32847939[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.16</ValMoy>
+          <PrevalenceGeographic id="24369">
+            <Name lang="cs">Francie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17637">
+          <Source>31552550[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="cs">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.2236</ValMoy>
+          <PrevalenceGeographic id="24607">
+            <Name lang="cs">Itálie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17638">
+          <Source>31552550[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="cs">Každoroční výskyt</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="cs">Hodnota a třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="cs">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.285</ValMoy>
+          <PrevalenceGeographic id="24607">
+            <Name lang="cs">Itálie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31460">
+      <OrphaCode>622925</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=622925</ExpertLink>
+      <Name lang="cs">X-vázaný syndrom těžkého aneuryzmatu a disekce hrudní aorty</Name>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17606">
+          <Source>27632686[PMID]_34807424[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>32.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17607">
+          <Source>27632686[PMID]_34807424[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31388">
+      <OrphaCode>618891</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=618891</ExpertLink>
+      <Name lang="cs">Chronický neuroviscerální deficit kyselé sfingomyelinázy</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17579">
+          <Source>20301544[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="cs">neznámý</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31370">
+      <OrphaCode>617910</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617910</ExpertLink>
+      <Name lang="cs">Maligní melanom spojivky</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17582">
+          <Source>31768361[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>32.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17583">
+          <Source>31768361[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31371">
+      <OrphaCode>617916</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617916</ExpertLink>
+      <Name lang="cs">Difuzní idiopatická hyperplázie plicních neuroendokrinních buněk</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17580">
+          <Source>30593169[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>100.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17581">
+          <Source>30593169[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31372">
+      <OrphaCode>617919</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=617919</ExpertLink>
+      <Name lang="cs">Autoinflamatorní syndrom spojený s chladem a genem F12</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17584">
+          <Source>31924766[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17585">
+          <Source>31924766[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31417">
+      <OrphaCode>619941</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619941</ExpertLink>
+      <Name lang="cs">Imunodeficit způsobený poruchou fagocytózy a migrace neutrofilů</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17596">
+          <Source>32128589[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17597">
+          <Source>32128589[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31416">
+      <OrphaCode>619367</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619367</ExpertLink>
+      <Name lang="cs">Autoinflamatorní syndrom spojený se SAMD9L</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17590">
+          <Source>31874111[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17591">
+          <Source>31874111[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31419">
+      <OrphaCode>619953</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619953</ExpertLink>
+      <Name lang="cs">Familiární hyperinflamatorní lymfoproliferativní imunodeficience</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17592">
+          <Source>32646852[PMID]_32647003[PMID]_32766723[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17593">
+          <Source>32646852[PMID]_32647003[PMID]_32766723[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31418">
+      <OrphaCode>619948</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619948</ExpertLink>
+      <Name lang="cs">Syndrom časné autoimunity, autoinflamace a imunodeficience</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17594">
+          <Source>34421895[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17595">
+          <Source>34421895[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31423">
+      <OrphaCode>619979</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619979</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující opožděný vývoj, imunodeficienci, leukoencefalopatii a hypohomocysteinémii</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17598">
+          <Source>29018201[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17599">
+          <Source>29018201[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31415">
+      <OrphaCode>619363</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619363</ExpertLink>
+      <Name lang="cs">Novorozenecké těžké multisystémové autoinflamatorní onemocnění se zvýšeným IL18</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17588">
+          <Source>31271789[PMID]_37741518[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17589">
+          <Source>31271789[PMID]_37741518[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31405">
+      <OrphaCode>619233</OrphaCode>
+      <ExpertLink lang="cs">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=cs&amp;Expert=619233</ExpertLink>
+      <Name lang="cs">Syndrom zahrnující dědičnou perzistenci fetálního hemoglobinu a mentální retardaci</Name>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17586">
+          <Source>27453576[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="cs">Případy / rodiny</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="cs">Případ</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="cs">Celosvětově</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="cs">Ověřeno</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17587">
+          <Source>27453576[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="cs">Bod prevalence</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="cs">Pouze třída</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="cs">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="cs">Celosvětově</Name>
           </PrevalenceGeographic>
